If you put $ 1,000 in the Chamath ‘SPAC KING’ PALIHAPIIEA, here is your return now
Shamath in Ghabitia, which was once the face of SPAC, has witnessed its struggle for the investment empire in recent years. The former executive director of Facebook has acquired investment capitalism that gained attention to taking many public companies through special purposes acquisition companies, a model that allowed companies to overcome traditional subscriptions.
However, with the transformation of market conditions and speculative enthusiasm, many of these investments were subjected to significant losses, which left investors questioning their belief in the so -called “Spac King”.
SPAC mutation declined
During the stock market group that dates back to the epidemic, Palihapitiya benefited from the presence of the media and the aggressive promotion of SPACS as a portal for retail investors to obtain early exposure to high -growth companies.
The social capital company launched several Spacs, all of which are under indicators that start with “public subscription” – from IPOA to IPOF – assembly of companies such as Virgin Galactic (Nyse: Space), Clover Health (Nasdaq: Clov), and OpenDoor Technologies (Nasdaq: Open) on public markets.
At its peak, these companies attracted strong attention to investors, but as economic conditions change, many SPAC -backed companies collapsed, some of them with more than 90 %.
Palm PalihaPITiya companies in some companies, including Sofi Technologies (NASDAQ: Sofi), led to criticism, comparing some of its early exits to withdrawing the classic rug. ‘
How to achieve a $ 1,000 investment in the Palihapitiya portfolio in 2025
Investors who bet 1000 dollars at the beginning of 2025 faced the Shamath companies in Space -backed, a turbulent trip, with Most stocks Struggle to restore the lost land.
Virgin Galactic, once seen as a changing games in traveling to commercial space and even Similar To Tesla (NASDAQ: TSLA) by analysts, has seen a decrease to $ 3.61, which represents a 38 % annual decrease.
The Cloover Health performance was a little better, as it was currently trading at $ 3.84, an increase of 21 % YTD, although it is still far from evaluating it once.

Opendoor Technologies, an online real estate platform, also fought under the weight of increased interest rates, as it decreased by 19 % to $ 1.29 at the time of the press.
Meanwhile, Prokidney (Nasdaq: Prok), a biotechnology company that develops cell treatments for kidney disease, fell to $ 1.16, a decrease of 31 % YTD.

To put the wallet performance in its correct perspective, a $ 1,000 virtual investment will remain equally across these four shares at the beginning of the year in red, which is now $ 832, which reflects a 16.75 % loss.
With many Spac companies now circulating in a small part of their peak assessments, the discussion continues on whether these declines are the result of the wider market conditions or a reflection of a system that prefers the first investors at the expense of the long -term shareholders.
Distinctive image from Shutterstock